Abby Johnson, an anti-abortion activist, questioned the safety of the pills and said in a statement: “While the abortion lobby will say this move is a huge step forward for women, it is only a step forward for them and those who It manufactures abortion pills because it means more money for them while throwing women under the bus.

Kirsten Moore, Director of expanding medication abortion access The project said: “By allowing brick-and-mortar pharmacies to provide medication abortion care, the FDA is treating medication abortion as safe, effective, time-sensitive care.”

Mifepristone is currently only approved for abortion. But it is also used to treat some miscarriages, and pharmacies may be under pressure to dispense it for that purpose as well. Recently, dozens of groups, including the American College of Obstetricians and Gynecologists and the American Medical Association, filed a petition. civil suit Asking the FDA to take action to ease the use of mifepristone for abortion.

An executive with Danko, which for years was the only company to produce the drug branded as Mifeprex, said the company expected smaller independent pharmacies to be the first to dispense the drug and that it would take longer for larger chains to be able to dispense the drug. partly because of the logistics involved in complying with the requirements.

The executive, who spoke on the condition of anonymity because of the company’s concerns about threats from abortion opponents, said a logistically complex move for large chains would be to enforce a requirement for the companies that pharmacies provide those health providers. Name confidential who prescribes mifepristone. The Danco official said a chain like CVS would not be able to list a doctor’s name in a company database, and would have to limit that information to the store that fills the doctor’s prescriptions.

She predicted that early adopters could include smaller pharmacies that typically serve university health services or retail pharmacies on hospital campuses, adding that the company was not expecting a sales boom from the rule change. She said it’s also possible that more health care providers would decide to become prescribers if they could now write prescriptions that could be filled instead of letting pharmacies stock the drug themselves.

“For some people, this is going to be a huge improvement in their ability to access the drug and may even be considered as an option on their own,” the Danko official said. “For other people, not necessarily. Maybe they don’t want to go to their little mom and pop pharmacy. They want to get it from a mail order where there’s no interaction like that.

Evan Massingill, chief executive officer of GenBioPro, which makes a generic version of mifepristone, said in a statement: “Today’s FDA announcement expands access to drugs that are essential for reproductive autonomy and is a step in the right direction that particularly needed to increase access to abortion care.

#FDA #abortion #pills #offered #retail #pharmacies

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *